Logo image of BON.PA

BONDUELLE SCA (BON.PA) Stock Fundamental Analysis

EPA:BON - Euronext Paris - Matif - FR0000063935 - Common Stock - Currency: EUR

8.68  -0.04 (-0.46%)

Fundamental Rating

3

BON gets a fundamental rating of 3 out of 10. The analysis compared the fundamentals against 58 industry peers in the Food Products industry. BON has a bad profitability rating. Also its financial health evaluation is rather negative. BON has a valuation in line with the averages, but on the other hand it scores bad on growth.


Dividend Valuation Growth Profitability Health

3

1. Profitability

1.1 Basic Checks

BON had negative earnings in the past year.
In the past year BON had a positive cash flow from operations.
Of the past 5 years BON 4 years were profitable.
Of the past 5 years BON 4 years had a positive operating cash flow.
BON.PA Yearly Net Income VS EBIT VS OCF VS FCFBON.PA Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 100M -100M 200M

1.2 Ratios

BON has a worse Return On Assets (-6.06%) than 81.03% of its industry peers.
BON has a Return On Equity of -21.14%. This is amonst the worse of the industry: BON underperforms 81.03% of its industry peers.
With a Return On Invested Capital value of 5.16%, BON perfoms like the industry average, outperforming 53.45% of the companies in the same industry.
BON had an Average Return On Invested Capital over the past 3 years of 3.87%. This is below the industry average of 6.77%.
The last Return On Invested Capital (5.16%) for BON is above the 3 year average (3.87%), which is a sign of increasing profitability.
Industry RankSector Rank
ROA -6.06%
ROE -21.14%
ROIC 5.16%
ROA(3y)-1.26%
ROA(5y)0.26%
ROE(3y)-4.23%
ROE(5y)0.55%
ROIC(3y)3.87%
ROIC(5y)4%
BON.PA Yearly ROA, ROE, ROICBON.PA Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 10 -10

1.3 Margins

BON's Operating Margin of 3.73% is in line compared to the rest of the industry. BON outperforms 44.83% of its industry peers.
In the last couple of years the Operating Margin of BON has declined.
With a Gross Margin value of 28.41%, BON is not doing good in the industry: 74.14% of the companies in the same industry are doing better.
BON's Gross Margin has been stable in the last couple of years.
Industry RankSector Rank
OM 3.73%
PM (TTM) N/A
GM 28.41%
OM growth 3Y7.56%
OM growth 5Y-6.54%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-0.27%
GM growth 5Y0.61%
BON.PA Yearly Profit, Operating, Gross MarginsBON.PA Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 10 20

2

2. Health

2.1 Basic Checks

The Return on Invested Capital (ROIC) is below the Cost of Capital (WACC), so BON is destroying value.
Compared to 1 year ago, BON has about the same amount of shares outstanding.
Compared to 5 years ago, BON has about the same amount of shares outstanding.
BON has a worse debt/assets ratio than last year.
BON.PA Yearly Shares OutstandingBON.PA Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 10M 20M 30M
BON.PA Yearly Total Debt VS Total AssetsBON.PA Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 500M 1B 1.5B 2B

2.2 Solvency

BON has an Altman-Z score of 1.92. This is not the best score and indicates that BON is in the grey zone with still only limited risk for bankruptcy at the moment.
BON's Altman-Z score of 1.92 is in line compared to the rest of the industry. BON outperforms 44.83% of its industry peers.
BON has a Debt/Equity ratio of 0.88. This is a neutral value indicating BON is somewhat dependend on debt financing.
BON has a Debt to Equity ratio of 0.88. This is in the lower half of the industry: BON underperforms 68.97% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.88
Debt/FCF N/A
Altman-Z 1.92
ROIC/WACC1
WACC5.16%
BON.PA Yearly LT Debt VS Equity VS FCFBON.PA Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 200M 400M 600M 800M

2.3 Liquidity

A Current Ratio of 1.33 indicates that BON should not have too much problems paying its short term obligations.
The Current ratio of BON (1.33) is comparable to the rest of the industry.
A Quick Ratio of 0.43 indicates that BON may have some problems paying its short term obligations.
BON has a worse Quick ratio (0.43) than 81.03% of its industry peers.
Industry RankSector Rank
Current Ratio 1.33
Quick Ratio 0.43
BON.PA Yearly Current Assets VS Current LiabilitesBON.PA Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 200M 400M 600M 800M 1B

2

3. Growth

3.1 Past

BON shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -8526.77%.
BON shows a decrease in Revenue. In the last year, the revenue decreased by -1.04%.
BON shows a decrease in Revenue. Measured over the last years, the Revenue has been decreasing by -3.11% yearly.
EPS 1Y (TTM)-8526.77%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-215.38%
Revenue 1Y (TTM)-1.04%
Revenue growth 3Y3.11%
Revenue growth 5Y-3.11%
Sales Q2Q%-1.74%

3.2 Future

Based on estimates for the next years, BON will show a quite strong growth in Earnings Per Share. The EPS will grow by 19.83% on average per year.
The Revenue is expected to grow by 2.07% on average over the next years.
EPS Next Y-1.1%
EPS Next 2Y20.04%
EPS Next 3Y19.83%
EPS Next 5YN/A
Revenue Next Year-6.23%
Revenue Next 2Y-2.15%
Revenue Next 3Y-0.62%
Revenue Next 5Y2.07%

3.3 Evolution

When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
BON.PA Yearly Revenue VS EstimatesBON.PA Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2016 2018 2020 2022 2024 2026 2028 2030 2032 500M 1B 1.5B 2B 2.5B
BON.PA Yearly EPS VS EstimatesBON.PA Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 0.5 1 1.5 2

4

4. Valuation

4.1 Price/Earnings Ratio

BON reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
The Price/Forward Earnings ratio is 6.88, which indicates a rather cheap valuation of BON.
Compared to the rest of the industry, the Price/Forward Earnings ratio of BON indicates a rather cheap valuation: BON is cheaper than 91.38% of the companies listed in the same industry.
BON is valuated cheaply when we compare the Price/Forward Earnings ratio to 21.90, which is the current average of the S&P500 Index.
Industry RankSector Rank
PE N/A
Fwd PE 6.88
BON.PA Price Earnings VS Forward Price EarningsBON.PA Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 10 20 30

4.2 Price Multiples

98.28% of the companies in the same industry are more expensive than BON, based on the Enterprise Value to EBITDA ratio.
Industry RankSector Rank
P/FCF N/A
EV/EBITDA 3.23
BON.PA Per share dataBON.PA EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 20 40 60

4.3 Compensation for Growth

A more expensive valuation may be justified as BON's earnings are expected to grow with 19.83% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y20.04%
EPS Next 3Y19.83%

2

5. Dividend

5.1 Amount

BON has a Yearly Dividend Yield of 2.33%.
Compared to an average industry Dividend Yield of 3.31, BON has a dividend in line with its industry peers.
Compared to an average S&P500 Dividend Yield of 2.42, BON has a dividend comparable with the average S&P500 company.
Industry RankSector Rank
Dividend Yield 2.33%

5.2 History

The dividend of BON decreases each year by -1.50%.
Dividend Growth(5Y)-1.5%
Div Incr Years0
Div Non Decr Years0
BON.PA Yearly Dividends per shareBON.PA Yearly Dividends per shareYearly Dividends per share 2018 2020 2021 2022 2023 2024 2025 0.1 0.2 0.3 0.4

5.3 Sustainability

BON has negative earnings and hence a negative payout ratio. The dividend may be in danger.
DP-6.39%
EPS Next 2Y20.04%
EPS Next 3Y19.83%
BON.PA Yearly Income VS Free CF VS DividendBON.PA Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 50M -50M 100M -100M 150M

BONDUELLE SCA

EPA:BON (7/4/2025, 12:46:10 PM)

8.68

-0.04 (-0.46%)

Chartmill FA Rating
GICS SectorConsumer Staples
GICS IndustryGroupFood, Beverage & Tobacco
GICS IndustryFood Products
Earnings (Last)05-06 2025-05-06
Earnings (Next)08-01 2025-08-01/amc
Inst Owners7.04%
Inst Owner ChangeN/A
Ins Owners0.33%
Ins Owner ChangeN/A
Market Cap283.23M
Analysts73.33
Price Target8.89 (2.42%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 2.33%
Yearly Dividend0.26
Dividend Growth(5Y)-1.5%
DP-6.39%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)-0.46%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)0%
EPS NY rev (3m)-2.94%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)0%
Revenue NY rev (3m)-3.61%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE 6.88
P/S 0.12
P/FCF N/A
P/OCF 4.12
P/B 0.46
P/tB 0.88
EV/EBITDA 3.23
EPS(TTM)-4.03
EYN/A
EPS(NY)1.26
Fwd EY14.54%
FCF(TTM)-0.34
FCFYN/A
OCF(TTM)2.11
OCFY24.26%
SpS69.82
BVpS18.75
TBVpS9.87
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -6.06%
ROE -21.14%
ROCE 7.24%
ROIC 5.16%
ROICexc 5.23%
ROICexgc 6.9%
OM 3.73%
PM (TTM) N/A
GM 28.41%
FCFM N/A
ROA(3y)-1.26%
ROA(5y)0.26%
ROE(3y)-4.23%
ROE(5y)0.55%
ROIC(3y)3.87%
ROIC(5y)4%
ROICexc(3y)4%
ROICexc(5y)4.09%
ROICexgc(3y)5.96%
ROICexgc(5y)6.3%
ROCE(3y)5.42%
ROCE(5y)5.61%
ROICexcg growth 3Y14.41%
ROICexcg growth 5Y-8.74%
ROICexc growth 3Y19.99%
ROICexc growth 5Y-5.6%
OM growth 3Y7.56%
OM growth 5Y-6.54%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-0.27%
GM growth 5Y0.61%
F-Score4
Asset Turnover1.07
Health
Industry RankSector Rank
Debt/Equity 0.88
Debt/FCF N/A
Debt/EBITDA 1.76
Cap/Depr 35.89%
Cap/Sales 3.5%
Interest Coverage 250
Cash Conversion 22.37%
Profit Quality N/A
Current Ratio 1.33
Quick Ratio 0.43
Altman-Z 1.92
F-Score4
WACC5.16%
ROIC/WACC1
Cap/Depr(3y)55.81%
Cap/Depr(5y)69.55%
Cap/Sales(3y)3.42%
Cap/Sales(5y)3.71%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-8526.77%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-215.38%
EPS Next Y-1.1%
EPS Next 2Y20.04%
EPS Next 3Y19.83%
EPS Next 5YN/A
Revenue 1Y (TTM)-1.04%
Revenue growth 3Y3.11%
Revenue growth 5Y-3.11%
Sales Q2Q%-1.74%
Revenue Next Year-6.23%
Revenue Next 2Y-2.15%
Revenue Next 3Y-0.62%
Revenue Next 5Y2.07%
EBIT growth 1Y33.82%
EBIT growth 3Y10.9%
EBIT growth 5Y-9.45%
EBIT Next Year1309.91%
EBIT Next 3Y146.14%
EBIT Next 5Y75.84%
FCF growth 1Y-71.89%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y31.64%
OCF growth 3YN/A
OCF growth 5YN/A